Oxytocic Pharmaceuticals Market to worth US$ 157.6 million by 2026 End
Future Market Insights has announced the addition of the “Oxytocic Pharmaceuticals Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Future Market Insights has announced the addition of the “Oxytocic Pharmaceuticals Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Europe Hospital Capacity Management Solutions <strong>Market</strong><br />
Global <strong>Oxy<strong>to</strong>cic</strong> pharmaceuticals <strong>Market</strong>: Regional Analysis<br />
The need for oxy<strong>to</strong>cic pharmaceuticals in the world will always remain contingent <strong>to</strong> the rise in pregnancy<br />
incidences and birth rate. Various parts of the world exhibit diverse birth rate, which incidentally drives<br />
the growth of their oxy<strong>to</strong>cic pharmaceuticals market, accordingly. In North America, oxy<strong>to</strong>cic<br />
pharmaceuticals are majorly used for postpartum haemorrhage, which is one of the most-prominent<br />
indication among labouring women in the US and Canada. However, China is expected <strong>to</strong> remain the<br />
largest market for oxy<strong>to</strong>cic pharmaceuticals in the world. Considering the country’s exploding birth rate,<br />
China’s oxy<strong>to</strong>cic pharmaceuticals market will be valued over <strong>US$</strong> 55 <strong>million</strong> <strong>by</strong> <strong>2026</strong>-end, expanding at<br />
9.8% CAGR. In 2016, Japan’s oxy<strong>to</strong>cic pharmaceuticals revenues amounted <strong>to</strong> an estimated <strong>US$</strong> 1.7<br />
<strong>million</strong>, while the oxy<strong>to</strong>cic pharmaceuticals market in Asia-Pacific excluding Japan & China (APEJC) region<br />
has been estimated <strong>to</strong> account for nearly 20% of global revenues.<br />
Global <strong>Oxy<strong>to</strong>cic</strong> <strong>Pharmaceuticals</strong> <strong>Market</strong>: Research Highlights<br />
Licensing agreements for development of newer oxy<strong>to</strong>cic pharmaceuticals is rampantly boosting the<br />
global market revenues, profiting local players as well as industry leaders.<br />
Surging prevalence of labour induction procedures for child births will continue promoting the use of<br />
oxy<strong>to</strong>cic pharmaceuticals throughout the forecast period.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 5